Akava Therapeutics: AKV9 targets mechanism in Alzheimer`s and ALS
06 May 2025 //
BUSINESSWIRE
Akava Congratulates Team on $7.3M Grant for Disease Research
17 Dec 2024 //
BUSINESSWIRE
Akava Announces Clearance of IND Application for Amyotrophic Lateral Sclerosis
22 Aug 2023 //
BUSINESSWIRE